These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 14736233)

  • 1. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
    Sivaraman S; Sullivan TJ; Johnson F; Novichenok P; Cui G; Simmerling C; Tonge PJ
    J Med Chem; 2004 Jan; 47(3):509-18. PubMed ID: 14736233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs.
    Sivaraman S; Zwahlen J; Bell AF; Hedstrom L; Tonge PJ
    Biochemistry; 2003 Apr; 42(15):4406-13. PubMed ID: 12693936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.
    Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA
    Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
    Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
    J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.
    Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW
    Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight through molecular mechanics Poisson-Boltzmann surface area calculations into the binding affinity of triclosan and three analogues for FabI, the E. coli enoyl reductase.
    Rafi SB; Cui G; Song K; Cheng X; Tonge PJ; Simmerling C
    J Med Chem; 2006 Jul; 49(15):4574-80. PubMed ID: 16854062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: a proposed mechanism for drug resistance.
    Protasevich II; Brouillette CG; Snow ME; Dunham S; Rubin JR; Gogliotti R; Siegel K
    Biochemistry; 2004 Oct; 43(42):13380-9. PubMed ID: 15491144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
    Heath RJ; Su N; Murphy CK; Rock CO
    J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis and mechanism of enoyl reductase inhibition by triclosan.
    Stewart MJ; Parikh S; Xiao G; Tonge PJ; Kisker C
    J Mol Biol; 1999 Jul; 290(4):859-65. PubMed ID: 10398587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant.
    Lee IH; Kim EJ; Cho YH; Lee JK
    Biochem Biophys Res Commun; 2002 Dec; 299(4):621-7. PubMed ID: 12459184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
    Suguna K; Surolia A; Surolia N
    Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.
    Heath RJ; Li J; Roland GE; Rock CO
    J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan.
    Kapoor M; Reddy CC; Krishnasastry MV; Surolia N; Surolia A
    Biochem J; 2004 Aug; 381(Pt 3):719-24. PubMed ID: 15086316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand- and Structure-Based Approaches of Escherichia coli FabI Inhibition by Triclosan Derivatives: From Chemical Similarity to Protein Dynamics Influence.
    Kronenberger T; de Oliveira Fernades P; Drumond Franco I; Poso A; Gonçalves Maltarollo V
    ChemMedChem; 2019 Dec; 14(23):1995-2004. PubMed ID: 31670463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic analysis of triclosan bound to enoyl reductase.
    Roujeinikova A; Levy CW; Rowsell S; Sedelnikova S; Baker PJ; Minshull CA; Mistry A; Colls JG; Camble R; Stuitje AR; Slabas AR; Rafferty JB; Pauptit RA; Viner R; Rice DW
    J Mol Biol; 1999 Nov; 294(2):527-35. PubMed ID: 10610777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
    Seefeld MA; Miller WH; Newlander KA; Burgess WJ; DeWolf WE; Elkins PA; Head MS; Jakas DR; Janson CA; Keller PM; Manley PJ; Moore TD; Payne DJ; Pearson S; Polizzi BJ; Qiu X; Rittenhouse SF; Uzinskas IN; Wallis NG; Huffman WF
    J Med Chem; 2003 Apr; 46(9):1627-35. PubMed ID: 12699381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
    Mehboob S; Truong K; Santarsiero BD; Johnson ME
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.
    Seefeld MA; Miller WH; Newlander KA; Burgess WJ; Payne DJ; Rittenhouse SF; Moore TD; DeWolf WE; Keller PM; Qiu X; Janson CA; Vaidya K; Fosberry AP; Smyth MG; Jaworski DD; Slater-Radosti C; Huffman WF
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2241-4. PubMed ID: 11527706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the variation in triclosan affinity to enoyl reductases.
    Pidugu LS; Kapoor M; Surolia N; Surolia A; Suguna K
    J Mol Biol; 2004 Oct; 343(1):147-55. PubMed ID: 15381426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.